Cargando…
Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report
Purpose. To present the case of a 27-year-old male patient with stage IV proliferative sickle cell retinopathy, treated with one intravitreal injection of ranibizumab, showing regression of the neovascularization and no recurrence at the 9-month follow-up. Methods. A 27-year-old male patient present...
Autores principales: | Mitropoulos, Panagiotis G., Chatziralli, Irini P., Parikakis, Efstratios A., Peponis, Vasileios G., Amariotakis, Georgios A., Moschos, Marilita M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258923/ https://www.ncbi.nlm.nih.gov/pubmed/25506450 http://dx.doi.org/10.1155/2014/682583 |
Ejemplares similares
-
Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
por: Karagiannis, Dimitrios, et al.
Publicado: (2017) -
Toric Intraocular Lens Implantation for Correction of Astigmatism in Cataract Patients with Corneal Ectasia
por: Parikakis, Efstratios A., et al.
Publicado: (2013) -
Photodynamic Therapy for Juxtapapillary Retinal Capillary Hemangioma
por: Mitropoulos, Panagiotis G., et al.
Publicado: (2014) -
Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report
por: Peponis, Vasileios G., et al.
Publicado: (2012) -
The Impact of Non-Steroidal Anti-Inflammatory Agents after Phacoemulsification on Quality of Life: A Randomized Study
por: Chatziralli, Irini P., et al.
Publicado: (2016)